S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:ABCO

Advisory Board (ABCO) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$53.75
$53.85
50-Day Range
N/A
52-Week Range
$30.40
$59.50
Volume
894,892 shs
Average Volume
788,742 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ABCO stock logo

About Advisory Board Stock (NASDAQ:ABCO)

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services. The best practices research and insight programs provide the foundation for all of its other programs. The Company offers technology analytics programs anchored by cloud-based software applications that surface performance improvement opportunities to accelerate progress. Through its consulting services, the Company provides on-the-ground support for performance improvement initiatives, as well as best practice professional management of areas of the hospital or medical group. The Company's data-enabled services are primarily focused in the area of enrollment management.

ABCO Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
BC3 board of trustees selects new interim president
Qlarant Announces Addition to Leadership Team
How to Craft a Winning Advisory Board
Arsenal Forms Digital, AI, and Data Analytics Group
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Arine Accelerates Growth, Expands Board of Directors
EQUINOX ANNOUNCES HEALTH ADVISORY BOARD
Access Announces Promotion of Tony Skarupa to CEO
Interwell Health Appoints Chief Growth Officer
See More Headlines
Receive ABCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advisory Board and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/27/2016
Today
4/19/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Research & Consulting Services
Current Symbol
NASDAQ:ABCO
CUSIP
00762W10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Robert W. Musslewhite J.D. (Age 47)
    Chairman of the Board, Chief Executive Officer
  • David L. Felsenthal (Age 46)
    President, Director
  • Michael T. Kirshbaum (Age 40)
    Chief Financial Officer, Treasurer
  • Richard A. Schwartz Ph.D. (Age 51)
    Chief Operating Officer - Health Care
  • Cormac F. Miller (Age 43)
    Chief Product Officer
  • Mary D. Van Hoose (Age 52)
    Chief Talent Officer
  • Evan R. Farber (Age 44)
    Chief Legal Officer and Corporate Secretary
  • Kelt Kindick (Age 62)
    Lead Independent Director
  • Sanjeev K. Bansal (Age 51)
    Independent Director
  • Peter J. Grua (Age 63)
    Independent Director

ABCO Stock Analysis - Frequently Asked Questions

How were Advisory Board's earnings last quarter?

The Advisory Board Company (NASDAQ:ABCO) released its quarterly earnings data on Wednesday, July, 27th. The business services provider reported $0.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.34 by $0.13. The business services provider earned $198.40 million during the quarter, compared to analysts' expectations of $196.49 million. Advisory Board's revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.40 EPS.

What other stocks do shareholders of Advisory Board own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Advisory Board investors own include Ixia (XXIA), Angi (ANGI), Bausch Health Companies (BHC), CBRE Group (CBRE), Carrizo Oil & Gas (CRZO), Arch Capital Group (ACGL), Adaptimmune Therapeutics (ADAP), Autodesk (ADSK), Agios Pharmaceuticals (AGIO) and AGNC Investment (AGNC).

This page (NASDAQ:ABCO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners